247 related articles for article (PubMed ID: 8150421)
1. Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
Mimura M; Makino H; Kanatsuka A; Asai T; Yoshida S
Horm Metab Res; 1994 Jan; 26(1):33-8. PubMed ID: 8150421
[TBL] [Abstract][Full Text] [Related]
2. Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.
Konukoglu D; Kemerli GD; Sabuncu T; Hatemi H
Clin Invest Med; 2003 Dec; 26(6):279-84. PubMed ID: 14690302
[TBL] [Abstract][Full Text] [Related]
3. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
[TBL] [Abstract][Full Text] [Related]
4. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
Raccah D; Gallice P; Pouget J; Vague P
Diabete Metab; 1992; 18(3):236-41. PubMed ID: 1327887
[TBL] [Abstract][Full Text] [Related]
5. Electrolytes and NA(+)-K(+)-ATPase: potential risk factors for the development of diabetic nephropathy.
Shahid SM; Mahboob T
Pak J Pharm Sci; 2008 Apr; 21(2):172-9. PubMed ID: 18390448
[TBL] [Abstract][Full Text] [Related]
6. Reduction of erythrocyte (Na(+)-K+) ATPase activities in non-insulin-dependent diabetic patients with hyperkalemia.
Mimura M; Makino H; Kanatsuka A; Yoshida S
Metabolism; 1992 Apr; 41(4):426-30. PubMed ID: 1313528
[TBL] [Abstract][Full Text] [Related]
7. C-peptide, Na+,K(+)-ATPase, and diabetes.
Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
[TBL] [Abstract][Full Text] [Related]
8. The role of endogenous Na+, K(+)-adenosine triphosphatase inhibitory factor in the regulation of membrane fluidity of erythrocytes in essential hypertension.
Tsuda K; Shima H; Takeda J; Kimura K; Nishio I; Masuyama Y
J Hypertens; 1992 Jul; 10(7):657-61. PubMed ID: 1321193
[TBL] [Abstract][Full Text] [Related]
9. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of erythrocyte (Na(+)-K+) ATPase activity in the diagnosis of diabetes mellitus and their complications].
Mimura M; Kanatsuka A; Makino H; Yoshida S
Nihon Rinsho; 1990 Dec; 48 Suppl():418-25. PubMed ID: 1964978
[No Abstract] [Full Text] [Related]
11. [Is there a relation between the presence in the serum of patients with arterial hypertension of a protein component with molecular weight of 15 kD and the inhibitory effect of the serum on Na,K-ATPase?].
Rogaeva EA; Perova NV; Aleksandrov AA; Oganov RG; Lopina OD
Vopr Med Khim; 1987; 33(4):34-9. PubMed ID: 2821695
[TBL] [Abstract][Full Text] [Related]
12. Endogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension.
Devynck MA; David-Dufilho M; Astarie C; Mazeaud M; Pernollet MG; Le Quan Sang KH
Physiol Bohemoslov; 1990; 39(1):71-8. PubMed ID: 2165268
[TBL] [Abstract][Full Text] [Related]
13. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients.
Vasdev S; Johnson E; Longerich L; Prabhakaran VM; Gault MH
Clin Nephrol; 1987 Apr; 27(4):169-74. PubMed ID: 3034459
[TBL] [Abstract][Full Text] [Related]
14. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane cationic fluxes in erythrocytes of diabetics and normal men.
Lijnen P; Fenyvesi A
Methods Find Exp Clin Pharmacol; 1994; 16(1):37-47. PubMed ID: 8164472
[TBL] [Abstract][Full Text] [Related]
16. [A study of Na(+)-K(+)-ATP ase activity in erythrocyte membrane from diabetic retinopathy patients].
He J; Qiu Y; Zhou X
Zhonghua Yan Ke Za Zhi; 1998 Nov; 34(6):421-3. PubMed ID: 11877243
[TBL] [Abstract][Full Text] [Related]
17. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
Djemli-Shipkolye A; Gallice P; Coste T; Jannot MF; Tsimaratos M; Raccah D; Vague P
Metabolism; 2000 Jul; 49(7):868-72. PubMed ID: 10909997
[TBL] [Abstract][Full Text] [Related]
18. Sodium transport across erythrocyte membranes in diabetes mellitus.
Jennings PE; Wilkins MR; West MJ; Kendall MJ; Barnett AH
Diabetes Res; 1986 Oct; 3(8):407-10. PubMed ID: 3028693
[TBL] [Abstract][Full Text] [Related]
19. [Changes in the activity of Na+ K+ ATPase in erythrocytes and immunoreactive plasma digoxin-like substances in chronic renal insufficiency: their relation to blood pressure levels].
Widimský J; Horký K; Lachmanová J; Dvoráková J
Vnitr Lek; 1988 Sep; 34(9):843-50. PubMed ID: 2849244
[No Abstract] [Full Text] [Related]
20. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
Maslova MN; Ogorodnikova LE; Titkov IuS
Fiziol Zh SSSR Im I M Sechenova; 1991 Sep; 77(9):232-7. PubMed ID: 1666609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
